Skip to content

Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?

Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04168047
Acronym
S3i
Enrollment
70
Registered
2019-11-19
Start date
2020-09-22
Completion date
2025-11-12
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Keywords

visceral hypersensitivity, Insomnia

Brief summary

Visceral hypersensitivity is frequent in IBS population up to 60% and is correlated with severity and altered quality of life. Sleeping troubles are most frequent in IBS population. Insomnia is a frequent disorder with an important cost for healthcare. Insomnia could decrease pain threshold. Visceral hypersensitivity was never measure in patients with insomnia. The hypothesis is IBS patients with insomnia probably have lower visceral pain threshold. The objective is to assess pain threshold during a barostat procedure in in IBS patients with or without insomnia in comparison with healthy volunteers or patients with insomnia. If the hypothesis are confirmed, insomnia should be look at in IBS patients and its treatments could improve visceral hypersensitivity and IBS symptoms.

Interventions

PROCEDUREBarostat procedure

Pressure threshold will be measured during the barostat procedure

OTHERAnxiety and Depression Evaluation

Anxiety and Depression will be measured using HAD anxiety and depression scale

Sleep quality will be measured using Pittsburg sleep quality index

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Healthy volunteers \- Person aged over 18 years with no IBS and no Insomnia 2. Patients with insomnia \- Patient aged over 18 years with no IBS and no Insomnia 3. Patients with IBS \- Patient aged over 18 years with IBS 4. patients with insomnia and IBS - Patient aged over 18 years with IBS

Exclusion criteria

* Active chronic organic disease * Endometriosis * Opioids consumption * Change in chronic treatment in the last 30 days * Hypersensitivity to Normacol * Patient with blood dyscrasia disorder known or identified, anticoagulant or antiplatelet treatments * Rectal pathology * Intestinal occlusion * Severe renal failure * Sodium retention * Anal pathology (anal fissure, hemorrhoidal thrombosis) * Person with administrative or judicial decision or under legal protection measure * Patient participating in another trial in the last 30 days * Pregnant or breastfeeding women * Impossibility to keep fasting for 12 hours

Design outcomes

Primary

MeasureTime frameDescription
Pressure threshold measured during the barostat procedureDay 35Pressure threshold measured during the barostat procedure

Secondary

MeasureTime frameDescription
Score at HAD anxiety and depression scaleDay 35Score at HAD anxiety and depression scale
Score at Pittsburg sleep quality indexDay 35Score at Pittsburg sleep quality index

Countries

France

Contacts

PRINCIPAL_INVESTIGATORChloé MECHIOR, MD

University Hospital, Rouen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026